PHARMAGEST INTER. Share Price Euronext Paris
Equities
FR0000077687
IT Services & Consulting
End-of-day quote
Other stock markets
|
||
- EUR | - |
02/04 | Equasens : RNPG virtually stable in 2023 | CF |
29/03 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
Sales 2023 | 220M 236M 19.73B | Sales 2024 * | 231M 249M 20.78B | Capitalization | 872M 938M 78.29B |
---|---|---|---|---|---|
Net income 2023 | 47M 50.58M 4.22B | Net income 2024 * | 49M 52.73M 4.4B | EV / Sales 2023 | 4.18 x |
Net cash position 2023 * | 35.92M 38.66M 3.23B | Net cash position 2024 * | 64.17M 69.05M 5.76B | EV / Sales 2024 * | 3.49 x |
P/E ratio 2023 |
19.5
x | P/E ratio 2024 * |
17.4
x | Employees | - |
Yield 2023 * |
2.09% | Yield 2024 * |
2.3% | Free-Float | 32.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 01/91/01 | |
Thierry Chapusot
FOU | Founder | 65 | 25/96/25 |
Director of Finance/CFO | - | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 25/96/25 |
Director/Board Member | 46 | 27/17/27 | |
Director/Board Member | 59 | 01/00/01 |
1st Jan change | Capi. | |
---|---|---|
-13.45% | 191B | |
+1.32% | 167B | |
+1.32% | 152B | |
+3.83% | 99.13B | |
+21.50% | 75.03B | |
-8.21% | 70.51B | |
-19.94% | 53.21B | |
-8.05% | 43.78B | |
+7.34% | 37.38B |